Laboratorios Farmaceuticos Rovi, S.A. Share Price CBOE
Stocks
0ILL
ES0157261019
Pharmaceuticals
OTC Markets Traded|
Real-time
CBOE
09:00:00 08/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 59.25 EUR | 0.00% |
|
0.00% | -1.74% |
| 05/10 | Spanish stocks - Factors to watch on Oct 5 | RE |
| 23/07 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 |
| Market Cap | 297.4Cr 333.03Cr 277.44Cr 252.02Cr 474.25Cr 32TCr 478.87Cr 3.33TCr 1.3TCr 16TCr 1.25TCr 1.22TCr 53TCr | P/E 2026 * |
19.6x | P/E 2027 * | 17.3x |
|---|---|---|---|---|---|
| Enterprise Value | 296.55Cr 332.08Cr 276.65Cr 251.3Cr 472.89Cr 32TCr 477.5Cr 3.32TCr 1.3TCr 16TCr 1.25TCr 1.22TCr 53TCr | EV / Sales 2026 * |
3.83x | EV / Sales 2027 * | 3.25x |
| Free-Float |
31.63% | Yield 2026 * |
1.67% | Yield 2027 * | 2% |
| Markets | Quality | ||
|---|---|---|---|
BME
| ROVI | Delayed | |
CBOE
| ROVIe | Real-time | |
|
OTC Markets
| LABFF | Delayed | |
|
Tradegate
| 41L | Real-time | |
|
Deutsche Boerse AG
| 41L | Delayed | |
|
CBOE
| 0ILL | Real-time | |
|
Börse Stuttgart
| 41L | Delayed | |
|
Boerse Muenchen
| 41L | Real-time | |
|
Wiener Boerse
| ROVI | End-of-day quote | |
|
Borsa Italiana
| 1ROVI | End-of-day quote |
Last Transcript: Laboratorios Farmaceuticos Rovi, S.A.
| 1 month | -0.59% | ||
| 3 months | +4.73% | ||
| 6 months | -26.19% | ||
| Current year | -1.74% |
| 1 week | 59.25 |  | 59.25 |
| 1 month | 59.25 | | 59.6 |
| 3 years | 46.36 | | 90.3 |
| 5 years | 35.3 | | 90.3 |
| 10 years | 10.95 | | 90.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 27/07/2007 | |
| Director of Finance/CFO | - | 01/01/2001 | |
| Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 17/07/2021 | |
| Director/Board Member | - | 27/07/2007 | |
| Director/Board Member | - | 27/07/2007 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | +0.81% | +17.21% | 333.03Cr | |
| -1.61% | +1.72% | +38.30% | +106.93% | 1,04300Cr | |
| -0.76% | -0.84% | +35.21% | +62.70% | 62TCr | |
| +0.39% | +4.81% | +17.81% | +83.77% | 48TCr | |
| -0.29% | -0.99% | +64.79% | +37.06% | 35TCr | |
| +1.26% | +3.24% | +21.56% | +42.28% | 34TCr | |
| +0.82% | +1.99% | +11.29% | +34.64% | 27TCr | |
| +1.04% | +1.23% | -7.14% | +10.69% | 24TCr | |
| -1.37% | +0.04% | +38.29% | +52.33% | 22TCr | |
| +0.17% | -0.27% | +24.40% | +96.82% | 18TCr | |
| Average | -0.02% | +0.28% | +24.53% | +54.44% | 41.63TCr | |
| Weighted average by Cap. | -0.33% | +0.60% | +30.53% | +69.08% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 77Cr 87Cr 72Cr 66Cr 123.44Cr 8.4TCr 124.64Cr 866.97Cr 339.09Cr 4.27TCr 325.45Cr 318.39Cr 14TCr | 89Cr 100Cr 83Cr 76Cr 142.31Cr 9.68TCr 143.7Cr 999.53Cr 390.94Cr 4.92TCr 375.22Cr 367.07Cr 16TCr |
| Net income | 15Cr 16Cr 14Cr 12Cr 23Cr 1.59TCr 24Cr 163.8Cr 64Cr 806.01Cr 61Cr 60Cr 2.59TCr | 17Cr 19Cr 16Cr 15Cr 28Cr 1.88TCr 28Cr 193.64Cr 76Cr 952.8Cr 73Cr 71Cr 3.06TCr |
| Net Debt | -84.99L -95.18L -79.29L -72.03L -1.36Cr -92Cr -1.37Cr -9.52Cr -3.72Cr -47Cr -3.57Cr -3.5Cr -150.64Cr | -7.25Cr -8.12Cr -6.76Cr -6.14Cr -12Cr -786.38Cr -12Cr -81Cr -32Cr -399.6Cr -30Cr -30Cr -1.29TCr |
| Date | Price | Change |
|---|---|---|
| 08/26/08 | €59.25 | -3.03% |
| 07/26/07 | €61.10 | 0.00% |
| 06/26/06 | €61.10 | 0.00% |
| 05/26/05 | €61.10 | 0.00% |
| 02/26/02 | €61.10 | 0.00% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ROVI Stock
- 0ILL Stock
Select your edition
All financial news and data tailored to specific country editions
